Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
Tesamorelin vs CJC-1295/Ipamorelin at a Glance Tesamorelin FDA Status FDA-approved (Egrifta, November 2010) CJC-1295/Ipam FDA Status Compounded (CJC-1295 reached Phase 2) Tesamorelin Mechanism GHRH receptor only (DPP-IV protected) CJC-1295/Ipam Mechanism GHRH + ghrelin receptor (dual pathway) Strongest Evidence Tesamorelin: 2 Phase 3 RCTs, 816 patients, CT-measured fat Most Popular CJC-1295/Ipamorelin (dual pathway, broader benefits) The Core Difference Tesamorelin and CJC-1295 both bind the GHRH receptor on pituitary somatotroph cells to stimulate growth hormone release
Vitamin C neutralizes free radicals and boosts immune health
Consistent Dosage: Each tablet contains a standardized 100 mg amount of glutathione
Direct evidence for the formation of a complex between 1-cysteine peroxiredoxin and glutathione S-transferase pi with activity changes in both enzymes
Interestingly, glutathione does the same for Vitamin C
Safe and Natural Extracts: Benefit from a formula enriched with plant-derived ingredients, ensuring a gentle yet effective skin brightening experience
US$ 25.12
US$ 21.96
US$ 20.91
US$ 27.62
US$ 23.86
